GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 239 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2019. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,013,000 | -11.9% | 236,158 | +0.9% | 0.02% | -16.7% |
| Q2 2020 | $14,772,000 | +542.5% | 234,158 | +420.4% | 0.02% | +350.0% |
| Q1 2020 | $2,299,000 | -31.9% | 45,000 | +5.9% | 0.00% | 0.0% |
| Q4 2019 | $3,378,000 | -0.6% | 42,501 | -39.3% | 0.00% | 0.0% |
| Q3 2019 | $3,397,000 | -25.6% | 70,000 | -19.4% | 0.00% | -20.0% |
| Q2 2019 | $4,566,000 | +67.5% | 86,800 | +68.5% | 0.01% | +66.7% |
| Q1 2019 | $2,726,000 | +87.1% | 51,500 | +45.1% | 0.00% | +50.0% |
| Q4 2018 | $1,457,000 | +411.2% | 35,500 | +373.3% | 0.00% | – |
| Q3 2018 | $285,000 | -15.9% | 7,500 | 0.0% | 0.00% | – |
| Q2 2018 | $339,000 | -54.1% | 7,500 | -51.0% | 0.00% | -100.0% |
| Q1 2018 | $739,000 | -16.5% | 15,300 | -32.0% | 0.00% | 0.0% |
| Q4 2017 | $885,000 | – | 22,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |